tbuckley/cabot-search huggingface dataset:
GENO-15IDENTIFICATION AND GENOMIC ANALYSIS OF HYPER-MUTATED AND ULTRA-MUTATED GBMS
Authors: E. Zeynep Erson-Omay, Nikolaus Schultz, S. Bulent Omay, Koray Ozduman, Akdes Serin Harmanci, Victoria Clark, Jacob Baranoski, Jennifer Moliterno Gunel, M. Necmettin Pamir, Kaya Bilguvar, Katsuhito Yasuno, Alexander Vortmeyer, Anita J. Huttner, Chris Sander, Murat Gunel
Journal: Neuro-Oncology (2015)

BACKGROUND: Somatic mutations on mismatch repair genes (MMR) or DNA polymerases define distinct molecular subgroups in many solid tumors with hyper or ultra mutated phenotypes. These subgroups, as recently reported, carry clinical significance by presenting favorable response to immunotherapies. METHODS: We have performed whole exome sequencing on 118 primary and secondary gliomas with matching blood samples. We analyzed our cohort based on level of mutation rate, mutation signature, clinical and histological attributes to identify the hyper/mutated gliomas. RESULTS: We have identified 7 outlier samples, with increased mutation burden compared to the rest of the cohort (mean = 2404 vs. 32.81, p.value= 0.03). 2/7 samples were primary GBMs and carried deleterious somatic mutations on the exonucelase domain of POLE gene. They were ultra-mutated (mean = 6253), with increased C > A transversions, had multi-nucleated giant cell histology, were younger at the time of diagnosis (average age, 35.5 vs 58y; p.value= 0.005) and had better prognosis. 5/7 of the outlier samples carried somatic mutations on the MMR genes (MSH6, MLH1 and MSH2) and displayed a hyper-mutated phenotype (mean = 864.4) with increased C > T transitions. 4/5 of the MMR deficient cases were previously treated, which might have induced the somatic mutations on the MMR genes. One of these hyper-mutated, MMR deficient GBM cases was later treated with targeted immunotherapy based on genomic analysis findings and had favorable results. CONCLUSION: Recent studies revealed that some solid cancers such as lung and colorectal cancer with increased mutation burden identified a subgroup that benefited from immunotherapy. We have identified and analyzed 2 sub-classes of gliomas with distinctive molecular attributes such as increased mutation burden, shifted mutation signature together with clinical attributes. As in the presented case of the hyper-mutated phenotype patient who underwent personalized immunotherapy, these subgroups can benefit from targeted therapies such as immunotherapy.
Multiple Transplant-Related Risk Factors for Hemolysis Including Major Kidd-Group Incompatibility Did Not Influence the Favourable Course of Unrelated Donor Bone Marrow Transplantation for Paroxysmal Nocturnal Hemoglobinuria.
Authors: Miroslaw Markiewicz, Iwona Wylezol, Sebastian Giebel, Malgorzata Krawczyk-Kulis, Jerzy Wojnar, Ewa Mendek-Czajkowska, Jerzy Holowiecki
Journal: Blood (2005)
Mam-Kind, a novel peer support intervention of motivational interviewing for breastfeeding maintenance: a feasibility study in the UK
Authors: Lauren Copeland, Laura Merrett, Aimee Grant, Rhiannon Phillips, Sally Tedstone, Julia Sanders, Mike Robling, Stephen Rollnick, Nina Gobat, Billie Hunter, Shantini Paranjothy
Journal: The Lancet (2016)
CHOP-R (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab) Compared to CPOP-R (Cyclophosphamide, Pixantrone, Vincristine, Prednisone, Rituxamib) in First-Line Therapy of Diffuse Large B Cell Lymphoma (DLBCL): An Interim Analysis.
Authors: Raoul Herbrecht, Stephen Couban, Florian Weissinger, Igor Gorbatchevsky, Richard H. van der Jagt
Journal: Blood (2007)
Increased γH2AX Foci in Old Hematopoietic Stem Cells Are Independent of the DNA Damage Response and Linked to Inefficient DNA Replication/Transcription
Authors: Johanna Flach, Sietske Bakker, Pauline Conroy, Damien Reynaud, Michelle M. Le Beau, Ciaran Morrison, Emmanuelle Passegué
Journal: Blood (2012)
Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice.
Authors: Hisashi Kato, Hirokazu Kashiwagi, Masamichi Shiraga, Shigenori Honda, Shigeki Miyata, Junichiro Yamamoto, Yoshiyuki Kurata, Tohru Funahashi, Iichiro Shimomura, Yoshiaki Tomiyama, Yuzuru Kanakura
Journal: Blood (2004)
Frequent PML-RAR α Mutations in Relapse Patients on Acute Promyelocytic Leukemia (APL) Intergroup Phase III Trial C9710.
Authors: Robert E. Gallagher, Esther L. Schachter-Tokarz, Barry K. Moser, Dorie Sher, Elisabeth Paietta, Martin S. Tallman, Clara D. Bloomfield, Bayard L. Powell, Richard A. Larson, Frederick R. Appelbaum, Cheryl L. Willman, Richard C. Harvey, Wendy Stock
Journal: Blood (2006)
Ras Signalling Pathway and Novel Target Genes Related to Down Syndrome Contribute to the Development of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in iAMP21 Patients
Authors: Sarra L Ryan, Vikki Rand, Claire Schwab, Heather Morrison, Elizabeth Matheson, Lynne Minto, Thahira Rahman, Bernard Keavney, Nicholas Bown, Roderick Skinner, Susanne Schnittger, Mauro Santibanez Koref, Vera Grossmann, Alexander Kohlmann, Julie Irving, Christine J Harrison
Journal: Blood (2011)
Ongoing Chronic GvHD Is the Most Harmful Factor for Sperm Recovery In Male Survivors After Allogeneic HSCT Not Conditioned with TBI.
Authors: Alicia Rovo, Maria Teresa van Lint, Mahmoud Aljurf, Nina Salooja, Gülsan Sucak, Ann Elizabeth Hunter, Tan Swee Kim, Gerard Socie, Manuela Badoglio, Andre Tichelli
Journal: Blood (2010)
Longitudinal and Functional Analysis of Spontaneous NY-ESO-1-Specific Antibody Responses in Multiple Myeloma Patients.
Authors: Sebastian Kobold, Yanran Cao, Sinje Tams, Britta Marlen Bartels, Tim Lütkens, Caroline Pabst, Andreas Marx, Friedrich Haag, Carsten Bokemeyer, Nikolaus Kroeger, Djordje Atanackovic
Journal: Blood (2009)
US sees rise in rare polio like syndrome of unknown cause
Authors: Michael McCarthy
Journal: BMJ (2016)

The US has seen a sharp increase in cases of a rare condition called acute flaccid myelitis (AFM), most recently in Washington state where eight children have been diagnosed in recent weeks.

The children, who range in age from four to 14, come from five different counties.

Scott Linquist, a state infectious diseases specialist, said that no common exposure had been identified. “At this …
Endoscopic management of gastric wall bleeding and stent blood clot occlusion after endoscopic ultrasound-guided hepaticogastrostomy
Authors: Caroline Fine, Jérome Rivory, Julien Forestier, Jean-Christophe Saurin, Leonardo Sosa-Valencia, Thierry Ponchon, Mathieu Pioche
Journal: Endoscopy (2016)

Hepaticogastrostomy is an alternative to biliary drainage after endoscopic retrograde cholangiopancreatography (ERCP) failure [1] [2]. However, this technique is associated with higher morbidity, including stent migration [3] and bleeding [4]. Bleeds are mostly due to pseudoaneurysm of the hepatic arteries [5].
Successful control of a large outbreak of HIV infection associated with injection of cathinone derivatives in Tel Aviv, Israel
Authors: E. Katchman, R. Ben-Ami, M. Savyon, D. Chemtob, B. Avidor, A. Wasserman, I. Zeldis, S. Girshengorn, Z. Amitai, R. Sheffer, D. Turner
Journal: Clinical Microbiology and Infection (2016)
Plasma Is a Reliable Source of mRNA for Testing IgVH Mutation Status in Patients with Chronic Lymphocytic Leukemia.
Authors: W. Ma, I. Jilani, M. Gorre, M. Keating, H. Chan, R. Tseng, H. Kantarjian, S. O’Brien, F. J. Giles, M. Albitar
Journal: Blood (2005)
Venous Thrombotic Events (VTEs) in Acute Myeloid Leukemia (AML) Patients During Induction Therapy (IT): Identifying Risk Factors, and Safety of Using Anticoagulation Therapy
Authors: Alaa Muslimani, Aya Rifai, Mohammad Muhsin Chisti, Ayham Ashkar, Kinda Muslemani, Jeffery Margolis, Laura Nadeau, Hong Ye, Mark Micale, James Huang, Ishmael Jaiyesimi
Journal: Blood (2011)
Particularities of pulmonary tuberculosis in elderly
Authors: Ines Zendah, Hamida Kwas, Aymen Ayari, Imen Elmjendel, Amel Khattab, Habib Ghedira
Journal: European Respiratory Journal (2013)

Introduction:  Elderly represents a high risk group to infections including tuberculosis. This may influence the presentation and the outcome of tuberculosis (TB) in this population.   Aim:  To determine epidemiologic, clinical, radiologic and outcome of pulmonary TB in patients older than 65 years.   Material and methods:  Retrospective study including 26 old patients (>65 years old) hospitalized in our department for tuberculosis.   Results:  There were 19 men and 5 women. The mean age was 68.6 years. Tobacco smoking was present in 17 patients (66%). Diabetes mellitus was present in 11 patients (42, 6%), arterial hypertension in 8 patients (30%) and chronic pulmonary lung disease in 6 cases (23%). Delay before seeking a doctor was 2 months. Clinical features were dominated by isolated deceased general status and fever (77%). Radiologic features were represented by extended bilateral infiltrates in 52 % of cases, associated to excavations in 23 % of cases. A pleural opacity related to effusion was present in 27% of cases. Acido-alcoolo-resistant bacilli were found in the expectorations in only 6 cases (23%). In 3 cases (12%), they were isolated thanks to fibro-aspiration. In the rest of cases were isolated only on culture. In 4 patients (15%), there was a delay (>1month) to bacilli negativation. Noteworthy complications during hospitalization were noted in 12 of cases (46.15%). Conclusion:  In elderly tuberculosis is particular by its inhabit clinical presentation leading to delayed diagnosis, by the atypical radiologic distribution of the lesions, the delay of negativation of the bacillus from the expectoration and the elevated complications of the disease; This is likely to be due to age and to comorbidties.
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial
Authors: Daniel F Hanley, Karen Lane, Nichol McBee, Wendy Ziai, Stanley Tuhrim, Kennedy R Lees, Jesse Dawson, Dheeraj Gandhi, Natalie Ullman, W Andrew Mould, Steven W Mayo, A David Mendelow, Barbara Gregson, Kenneth Butcher, Paul Vespa, David W Wright, Carlos S Kase, J Ricardo Carhuapoma, Penelope M Keyl, Marie Diener-West, John Muschelli, Joshua F Betz, Carol B Thompson, Elizabeth A Sugar, Gayane Yenokyan, Scott Janis, Sayona John, Sagi Harnof, George A Lopez, E Francois Aldrich, Mark R Harrigan, Safdar Ansari, Jack Jallo, Jean-Louis Caron, David LeDoux, Opeolu Adeoye, Mario Zuccarello, Harold P Adams, Michael Rosenblum, Richard E Thompson, Issam A Awad
Journal: The Lancet (2017)
Molecular Detection of Minimal Residual Disease Based on NPM1-Real-Time PCR At the Time of Complete Remission Is a Strong Predictor of Disease Free and Overall Survival in AML
Authors: Christian Thiede, Nona Shayegi, Michael Kramer, Martin Bornhäuser, Markus Schaich, Johannes Schetelig, Uwe Platzbecker, Christoph Röllig, Gerhard Ehninger
Journal: Blood (2011)
Neutrophil Elastase Modulates Granulopoiesis through the Interaction of G-CSF and G-CSF Receptor.
Authors: Takashi Sato, Masakazu Habara, Hiroki Kihara, Hiroshi Kawaguchi, Kazuhiro Nakamura, Satoshi Okada, Nobutsune Ishikawa, Norioki Ohno, Masao Kobayashi
Journal: Blood (2005)
Hematopoietic Stem Cell Transplantation (HSCT) Benefits the Survival of Acute Myeloid Leukemia (AML) Patients with IDH1, NRAS and DNMT3A Mutations
Authors: Yang Xu, Zhen Yang, Hong Tian, Huiying Qiu, Aining Sun, Suning Chen, Wu Depei
Journal: Blood (2012)
Degradation of TRAF6 by Bortezomib-Induced Autophagy Contributes to Cell Death in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Authors: Jing Fang, Lyndsey Bolanos, Garrett Rhyasen, Carmen Rigolino, Agostino Cortelezzi, Esther Natalie Oliva, Mariella Cuzzola, Daniel T Starczynowski
Journal: Blood (2011)
Genetic polymorphisms and ethnic difference in outcome of adjuvant FOLFOX chemotherapy in Korean patients with colon cancer.
Authors: Kyung-Hun Lee, Hye Jung Chang, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Yung-Jue Bang, Sun Young Kim, Keun-Wook Lee, Jee Hyun Kim, Yong Sang Hong, Tae Won Kim, Young Suk Park, Won Ki Kang, Sang Joon Shin, Joong Bae Ahn, Gyeong Hoon Kang, Seung-Yong Jeong, Kyu Joo Park, Jae-Gahb Park, Tae-You Kim
Journal: Journal of Clinical Oncology (2012)

623 Background: Ethnic diversity of genetic polymorphism can result in individual differences in the efficacy and toxicity of cancer chemotherapy. Methods: A total of 292 Korean patients (183 men and 109 women) from six hospitals in Korea were prospectively enrolled. Patients had resected stage III or high-risk stage II colon cancer and were treated with 12 cycles of adjuvant oxaliplatin plus leucovorin plus 5-fluorouracil (FOLFOX) chemotherapy. 20 germline polymorphisms in 10 genes (TS, MTHFR, ERCC1, XPD, XRCC1, ABCC2, AGXT, GSTP1, GSTT1 and GSTM1) were analyzed from peripheral blood. TS genotype in 5’UTR was classified as ‘high’ (2R/3G, 3C/3G, and 3G/3G) or ‘low’ (2R/2R, 2R/3C, and 3C/3C). Results: Most patients (86.3%) received 12 complete cycles of FOLFOX chemotherapy. In contrast to previous studies in Caucasians, neutropenia (grade 3–4, 60.5%) was frequently observed in our Korean patients, whereas only 16.4% experienced grade 2 or more sensory neuropathy. Neutropenia was more frequent in MTHFR 677TT [adjusted odds ratio (OR) 2.32, 95% confidence interval (CI) 1.19–4.55] and ERCC1 19007TT (adjusted OR 4.58, 95% CI 1.20–17.40) genotypes. Patients harboring XRCC1 23885GG had lower risk of neuropathy (adjusted hazard ratio 0.56, 95% CI 0.32-0.99) and longer time to the onset of grade 2-4 neuropathy. MTHFR 677TT and XRCC1 23885GG genotype was also more prevalent in Koreans compared to Caucasians, and the difference of genotypic frequency could partly explain the ethnically different toxicity profile. After median 49.4 months of follow-up, there were 58 (19.9%) relapses and 19 (6.5%) deaths. TS ‘low’ genotype [adjusted hazard ratio (OR) 1.83, 95% CI 1.003–3.34] was significantly related to shorter disease-free survival. Overall survival was not significantly different according to the polymorphisms. Conclusions: Polymorphisms in MTHFR, XRCC1 and TS are related to toxicities and disease-free survival in patients with colon cancer. These polymorphisms may explain the ethnic difference in toxicity profile following adjuvant FOLFOX chemotherapy.
IMPS-10BRAF<sup>V600E</sup>-MUTANT IMMUNOCOMPETENT GLIOMA MODEL EXHIBITS TYPICAL HISTOPATHOLOGICAL FEATURES OF HUMAN GLIOBLASTOMA MULTIFORME
Authors: Stefan Grossauer, Katharina Koeck, Banafsheh Kadkhodaei, Ian Meyers, Jennifer Leddy, Hannah Collins, Claudia Petritsch
Journal: Neuro-Oncology (2015)

INTRODUCTION: Targeted monotherapy against BRAFV600E displays efficacy in preclinical models of BRAFV600E-mutant gliomas, however xenograft tumors adapt rapidly and escape from the growth-inhibitory effects. The question emerges whether a more durable anti-tumor effect will be achieved by combining BRAF inhibitors with immune-modulatory agents such as anti-CTLA-4 and anti-PD-L1. The lack of an immunocompetent preclinical model of BRAFV600E-mutant astrocytoma however has been prohibitive to addressing this question. METHODS: A BRAFV600E-mutant murine tumor cell line (2341) was isolated from tumors developed in transgenic mice with Cre-conditional alleles of BRAFV600E and CDKN2A. Multiple cohorts of syngeneic FVBN mice, as well as athymic mice were injected orthotopically with the BRAFV600E-mutant tumor cell line and evaluated for the occurrence of neurological symptoms. Symptomatic animals were sacrificed and brains were harvested and subjected to a detailed immunohistopathological characterization. Tumor growth was studied employing bioluminescence (BLI). The presence of tumor fluorescence following in vivo injection of 5-aminolevulinic acid (5-ALA) was investigated as well. RESULTS: Injected animals developed tumors in the right striatum exhibiting all histopathological diagnostic features of human glioblastomas. Neurological free survival was significantly longer in immunocompetent FVBN mice (mean 56 days) compared to similarly treated athymic mice (mean 15 days). Additionally, 5-ALA injected mice exhibited strong fluorescence of tumor cells, when exposed to ultraviolet light compared to normal brain tissue. Results from ongoing work regarding T-cell regulation in the immunocompetent glioma model will be presented and discussed at the meeting. CONCLUSIONS: A BRAFV600E-mutant glioma model that recapitulates the typical genetical, histopathological and behavioral features of human glioblastoma multiforme can be established in fully immunocompetent FVBN mice. These tumors also exhibit 5-ALA induced tumor fluorescence, a typical feature of human malignant astrocytomas. Further studies will reveal this modelś ability to reliably test the anti-glioma efficacy of immune-modulatory drugs in combination with BRAFV600E inhibition.
FRI0301 Prognosis of The Idiopathic Inflammatory Myopathies Associated with Interstitial Lung Disease: Preliminary Analysis of The Registry Remicam
Authors: T. Cobo-Ibáñez, L. Nuño, M.J. García, B. Joven, V. Maldonado, I. Llorente, C. Barbadillo, P. Garcia De La Peña, L. Ruiz, H. Moruno, R. Almodόvar, L. Lojo, F.J. Lόpez-Longo
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> Some studies suggest that clinical subgroups of idiopathic inflammatory myopathies (IIM) and several myositis-specific antibodies (MSAs) could influence the prognosis of IIM with interstitial lung disease (ILD). <h3>Objectives</h3> To investigate the prognosis value of different clinical subgroups and of MSAs in a cohort of patients with IIM -associated ILD. <h3>Methods</h3> We analyzed patients with IIM-associated ILD included in the multicenter registry REMICAM (1980–2014). We compared prognosis between a) subgroups of IIM: dermatomyositis (DM) vs. polymiosytis (PM) (primary, juvenile, cancer-associated myositis or overlap myositis); and b) absence (−) or presence (+) of anti-Jo1 vs. anti-RO vs. anti-Jo1 and anti-RO. In this preliminary analysis, outcomes were mortality and change between final and initial visit in FVC and DLCO. <h3>Results</h3> 478 patients were included in the registry, of which 143 had ILD, 66% PM and 34% DM. The distribution by MSAs was: 56% anti-Jo1-/RO-, 20% anti-Jo1+, 9% anti-RO+ and 15% anti-Jo1+/RO+. There were 52 deaths; the main causes were 32.6% cardiovascular events and 22.4% infections without difference between subgroups of IIM. The probability of survival was 50% to 18.8 years and the mortality rate was 37.7/1000 patient-ys. We did not find differences when we compared survival between subgroups of IIM or we compared by MSAs. FVC seemed to improve more in DM than in PM patients (1.2±5.2vs. 0.5±4.7;p=0.059), but there were no significant changes in DLCO of DM patients or in FVC and DLCO according to MSAs. <h3>Conclusions</h3> We did not find prognostic differences in the causes of mortality, mortality rate between subgroups of IIM, or in mortality rate according to MSAs in patients with ILD. In DM patients there was a trend towards a greater improvement of FVC than in PM patients. <h3>Disclosure of Interest</h3> None declared
The Oxazolidinone Derivative Locostatin Induces Apoptosis in CLL Cells through Inhibition of AKT and MAPK-ERK1/2 Signaling Under Conditions That Mimic the Tumor Microenvironment
Authors: Oliver Giles Best, Tahni Pyke, Kyle Crassini, William S Stevenson, Stephen P. Mulligan
Journal: Blood (2014)
CD68+ Tumor-Associated Macrophages Predict Unfavorable Treatment Outcomes in Classic Hodgkin's Lymphoma in Correlation with Early FDG-PET Assessment Results
Authors: Mohamed Touati, Manuela Delage-Corre, Jacques Monteil, Agnes Olivrie-Gamaury, Stephane Moreau, Liliane Remenieras, Marie-Pierre Gourin, Julie Abraham, Nataliya Dmytruk, Arnaud Jaccard, Dominique Bordessoule
Journal: Blood (2011)
High-Resolution SNP 6.0 Array Profiling Discloses Novel Genomic Aberrations in Polycythemia Vera and Essential Thrombocythemia.
Authors: Marta Anna Sobas, Teresa Gonzalez, Manuel Perez-Encinas, Celsa Quinteiro, Jose Diaz, Natalia Alonso, Angeles Bendaña, Marta Sonia Gonzalez, Maria-Jose Rabuñal, Jose Luis Bello-Lopez
Journal: Blood (2009)
Patient Navigation for Comprehensive Cancer Screenings in High-Risk Patients
Authors: Fei Wu, Akihiko Ozaki, Genming Zhao
Journal: JAMA Internal Medicine (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain
Authors: Donald D Raymond, Shaun M Stewart, Jiwon Lee, Jack Ferdman, Goran Bajic, Khoi T Do, Michael J Ernandes, Pirada Suphaphiphat, Ethan C Settembre, Philip R Dormitzer, Giuseppe Del Giudice, Oretta Finco, Tae Hyun Kang, Gregory C Ippolito, George Georgiou, Thomas B Kepler, Barton F Haynes, M Anthony Moody, Hua-Xin Liao, Aaron G Schmidt, Stephen C Harrison
Journal: Nature Medicine (2016)
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy
Authors: Christophe Adrie, Maité Garrouste-Orgeas, Wafa Ibn Essaied, Carole Schwebel, Michael Darmon, Bruno Mourvillier, Stéphane Ruckly, Anne-Sylvie Dumenil, Hatem Kallel, Laurent Argaud, Guillaume Marcotte, Francois Barbier, Virginie Laurent, Dany Goldgran-Toledano, Christophe Clec'h, Elie Azoulay, Bertrand Souweine, Jean-François Timsit, Jean-François Timsit, Elie Azoulay, Yves Cohen, Maïté Garrouste-Orgeas, Lilia Soufir, Alban Le Monnier, Jean-Ralph Zahar, Christophe Adrie, Michael Darmon, Corinne Alberti, Christophe Clec'h, Jean-Francois Timsit, Sebastien Bailly, Stéphane Ruckly, Cecile Pommier, Wafa Ifn Essaeid, Aurélien Vannieuwenhuyze, Bernard Allaouchiche, Claire Ara-Somohano, Laurent Argaud, Francois Barbier, Jean-Pierre Bedos, Agnès Bonadona, Anne-Laure Borel, Caroline Bornstain, Lila Bouadma, Alexandre Boyer, Jean-Pierre Colin, Anne-Sylvie Dumenil, Antoine Gros, Rebecca Hamidfar-Roy, Hakim Haouache, Samir Jamali, Hatem Kallel, Guillaume Marcotte, Alexandre Lautrette, Christian Laplace, Benoit Misset, Laurent Montesino, Bruno Mourvillier, Benoît Misset, Guillaume Lacave, Virgine Lemiale, Virginie Laurent, Eric Marriotte, Benjamin Planquette, Jean Reignier, Romain Sonneville, Bertrand Souweine, Carole Schwebel, Gilles Troché, Marie Thuong, Dany Goldgran-Toledano, Eric Vantalon, Caroline Tournegros, Loïc Ferrand, Nadira Kaddour, Boris Berthe, Kaouttar Mellouk, Sophie Letrou, Igor Théodose, Julien Fournier, Véronique Deiler
Journal: Journal of Infection (2016)
High Dose Chemoradiotherapy and ASCT Can Overcome the Prognostic Importance of Bcl-2, Bim, and p53 in Relapsed/Refractory Hodgkin’s Lymphoma.
Authors: Daniel Persky, Julie Teruya-Feldstein, Tarun Kewalramani, Pauline D. Bonner, Alexia Iasonos, David Rice, Joachim Yahalom, Stephen D. Nimer, Andrew D. Zelenetz, Craig H. Moskowitz
Journal: Blood (2005)
Long-Term Outcome of Lower-Risk MDS Patients after Immunosuppressive Therapy (IST) with Anti-Thymocyte Globulin (ATG)+/- Cyclosporin A (CsA)
Authors: Charikleia Kelaidi, Thorsten Braun, Gregory Lazarian, Juliette Soret, Sophie Cereja, Virginie Eclache, Daniel Lusina, Lionel Adès, Antoine Martin, Pierre Fenaux, Claude Gardin
Journal: Blood (2014)